Roche Targets Emerging Oncology Market With New Lung-Cancer Drug - WSJ

Roche Targets Emerging Oncology Market With New Lung-Cancer Drug WSJRoche says divarasib cut risk of death 44% in lung cancer trial ReutersESMO: Roche touts ‘convincing’ phase 3 KRAS data after win over rivals Fierce BiotechRoche Drug Outshines Amgen, Bristol Rivals in Lung Cancer Study Bloomberg.comRoche takes victory lap with lung cancer pill's win over Amgen, Bristol Myers Endpoints News